A citation-based method for searching scientific literature

Cher Y Enderby, Charles Burger. Ther Adv Chronic Dis 2015
Times Cited: 18







List of co-cited articles
91 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.
Nazzareno Galiè, Joan A Barberà, Adaani E Frost, Hossein-Ardeschir Ghofrani, Marius M Hoeper, Vallerie V McLaughlin, Andrew J Peacock, Gérald Simonneau, Jean-Luc Vachiery, Ekkehard Grünig,[...]. N Engl J Med 2015
628
38

Macitentan and morbidity and mortality in pulmonary arterial hypertension.
Tomás Pulido, Igor Adzerikho, Richard N Channick, Marion Delcroix, Nazzareno Galiè, Hossein-Ardeschir Ghofrani, Pavel Jansa, Zhi-Cheng Jing, Franck-Olivier Le Brun, Sanjay Mehta,[...]. N Engl J Med 2013
809
38

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial.
N Galiè, Lj Rubin, Mm Hoeper, P Jansa, H Al-Hiti, Gmb Meyer, E Chiossi, A Kusic-Pajic, G Simonneau. Lancet 2008
637
27

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.
G E D'Alonzo, R J Barst, S M Ayres, E H Bergofsky, B H Brundage, K M Detre, A P Fishman, R M Goldring, B M Groves, J T Kernis. Ann Intern Med 1991
27


Updated treatment algorithm of pulmonary arterial hypertension.
Nazzareno Galiè, Paul A Corris, Adaani Frost, Reda E Girgis, John Granton, Zhi Cheng Jing, Walter Klepetko, Michael D McGoon, Vallerie V McLaughlin, Ioana R Preston,[...]. J Am Coll Cardiol 2013
444
22

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.
R J Barst, L J Rubin, W A Long, M D McGoon, S Rich, D B Badesch, B M Groves, V F Tapson, R C Bourge, B H Brundage,[...]. N Engl J Med 1996
22


Selexipag for the Treatment of Pulmonary Arterial Hypertension.
Olivier Sitbon, Richard Channick, Kelly M Chin, Aline Frey, Sean Gaine, Nazzareno Galiè, Hossein-Ardeschir Ghofrani, Marius M Hoeper, Irene M Lang, Ralph Preiss,[...]. N Engl J Med 2015
502
22

Characterization of first-time hospitalizations in patients with newly diagnosed pulmonary arterial hypertension in the REVEAL registry.
Charles D Burger, Pamela K Long, Monarch R Shah, Michael D McGoon, Dave P Miller, Alain J Romero, Wade W Benton, Robert E Safford. Chest 2014
53
22


Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonist.
Marc Iglarz, Christoph Binkert, Keith Morrison, Walter Fischli, John Gatfield, Alexander Treiber, Thomas Weller, Martin H Bolli, Christoph Boss, Stephan Buchmann,[...]. J Pharmacol Exp Ther 2008
227
22

Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
Gérald Simonneau, David Montani, David S Celermajer, Christopher P Denton, Michael A Gatzoulis, Michael Krowka, Paul G Williams, Rogerio Souza. Eur Respir J 2019
22


Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study.
Marius M Hoeper, Robyn J Barst, Robert C Bourge, Jeremy Feldman, Adaani E Frost, Nazzareno Galié, Miguel Angel Gómez-Sánchez, Friedrich Grimminger, Ekkehard Grünig, Paul M Hassoun,[...]. Circulation 2013
367
16

Modern age pathology of pulmonary arterial hypertension.
Elvira Stacher, Brian B Graham, James M Hunt, Aneta Gandjeva, Steve D Groshong, Vallerie V McLaughlin, Marsha Jessup, William E Grizzle, Michaela A Aldred, Carlyne D Cool,[...]. Am J Respir Crit Care Med 2012
380
16

Riociguat for the treatment of pulmonary arterial hypertension.
Hossein-Ardeschir Ghofrani, Nazzareno Galiè, Friedrich Grimminger, Ekkehard Grünig, Marc Humbert, Zhi-Cheng Jing, Anne M Keogh, David Langleben, Michael Ochan Kilama, Arno Fritsch,[...]. N Engl J Med 2013
791
16

Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension.
Vallerie McLaughlin, Richard N Channick, Hossein-Ardeschir Ghofrani, Jean-Christophe Lemarié, Robert Naeije, Milton Packer, Rogério Souza, Victor F Tapson, Jonathan Tolson, Hikmet Al Hiti,[...]. Eur Respir J 2015
142
16

Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report.
Darren B Taichman, Joe Ornelas, Lorinda Chung, James R Klinger, Sandra Lewis, Jess Mandel, Harold I Palevsky, Stuart Rich, Namita Sood, Erika B Rosenzweig,[...]. Chest 2014
171
16

The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension.
Raymond L Benza, Mardi Gomberg-Maitland, Dave P Miller, Adaani Frost, Robert P Frantz, Aimee J Foreman, David B Badesch, Michael D McGoon. Chest 2012
327
16

Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry.
David B Badesch, Gary E Raskob, C Greg Elliott, Abby M Krichman, Harrison W Farber, Adaani E Frost, Robyn J Barst, Raymond L Benza, Theodore G Liou, Michelle Turner,[...]. Chest 2010
743
16


Slow receptor dissociation kinetics differentiate macitentan from other endothelin receptor antagonists in pulmonary arterial smooth muscle cells.
John Gatfield, Celia Mueller Grandjean, Thomas Sasse, Martine Clozel, Oliver Nayler. PLoS One 2012
124
16

Bosentan therapy for pulmonary arterial hypertension.
Lewis J Rubin, David B Badesch, Robyn J Barst, Nazzareno Galie, Carol M Black, Anne Keogh, Tomas Pulido, Adaani Frost, Sebastien Roux, Isabelle Leconte,[...]. N Engl J Med 2002
16

SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension.
Nazzareno Galiè, Pavel Jansa, Tomás Pulido, Richard N Channick, Marion Delcroix, Hossein-Ardeschir Ghofrani, Franck-Olivier Le Brun, Sanjay Mehta, Loïc Perchenet, Lewis J Rubin,[...]. Eur Heart J 2017
46
16

Clinical efficacy and safety of switch from bosentan to macitentan in children and young adults with pulmonary arterial hypertension.
Ebru Aypar, Dursun Alehan, Tevfik Karagöz, Hayrettin Hakan Aykan, İlker Ertugrul. Cardiol Young 2018
9
33

Treatment goals of pulmonary hypertension.
Vallerie V McLaughlin, Sean Patrick Gaine, Luke S Howard, Hanno H Leuchte, Michael A Mathier, Sanjay Mehta, Massimillano Palazzini, Myung H Park, Victor F Tapson, Olivier Sitbon. J Am Coll Cardiol 2013
199
11

Cardiopulmonary exercise testing in patients with pulmonary arterial hypertension: an evidence-based review.
Ross Arena, Carl J Lavie, Richard V Milani, Jonathan Myers, Marco Guazzi. J Heart Lung Transplant 2010
108
11

The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries.
Adaani E Frost, David B Badesch, Robyn J Barst, Raymond L Benza, C Gregory Elliott, Harrison W Farber, Abby Krichman, Theodore G Liou, Gary E Raskob, Prieya Wason,[...]. Chest 2011
209
11


An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry.
Raymond L Benza, Dave P Miller, Robyn J Barst, David B Badesch, Adaani E Frost, Michael D McGoon. Chest 2012
641
11

Pulmonary arterial hypertension.
Lewis J Rubin. Proc Am Thorac Soc 2006
64
11

Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene.
Z Deng, J H Morse, S L Slager, N Cuervo, K J Moore, G Venetos, S Kalachikov, E Cayanis, S G Fischer, R J Barst,[...]. Am J Hum Genet 2000
806
11

The Fifth World Symposium on Pulmonary Hypertension.
Nazzareno Galiè, Gerald Simonneau. J Am Coll Cardiol 2013
83
11

Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension.
M Humbert, O Sitbon, A Yaïci, D Montani, D S O'Callaghan, X Jaïs, F Parent, L Savale, D Natali, S Günther,[...]. Eur Respir J 2010
449
11

Molecular pathogenesis of pulmonary arterial hypertension.
Marlene Rabinovitch. J Clin Invest 2012
455
11

Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis.
M Sean McMurtry, Sebastien Bonnet, Xichen Wu, Jason R B Dyck, Alois Haromy, Kyoko Hashimoto, Evangelos D Michelakis. Circ Res 2004
347
11


Genomics of pulmonary arterial hypertension: implications for therapy.
Mark W Geraci, Todd M Bull, Rubin M Tuder. Heart Fail Clin 2010
9
22

Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension.
K B Lane, R D Machado, M W Pauciulo, J R Thomson, J A Phillips, J E Loyd, W C Nichols, R C Trembath. Nat Genet 2000
11

FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension.
Edda Spiekerkoetter, Xuefei Tian, Jie Cai, Rachel K Hopper, Deepti Sudheendra, Caiyun G Li, Nesrine El-Bizri, Hirofumi Sawada, Roxanna Haghighat, Roshelle Chan,[...]. J Clin Invest 2013
271
11

Survival in primary pulmonary hypertension: the impact of epoprostenol therapy.
Vallerie V McLaughlin, Alicia Shillington, Stuart Rich. Circulation 2002
805
11

Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study): a randomized controlled trial.
Victor F Tapson, Zhi-Cheng Jing, Kai-Feng Xu, Lei Pan, Jeremy Feldman, David G Kiely, Eugene Kotlyar, C Shane McSwain, Kevin Laliberte, Carl Arneson,[...]. Chest 2013
204
11

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.
Olivier Sitbon, Marc Humbert, Hilario Nunes, Florence Parent, Gilles Garcia, Philippe Hervé, Maurizio Rainisio, Gérald Simonneau. J Am Coll Cardiol 2002
990
11

Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gap.
Vallerie V McLaughlin, Anatoly Langer, Mary Tan, Philip J Clements, Ronald J Oudiz, Victor F Tapson, Richard N Channick, Lewis J Rubin. Chest 2013
86
11

Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trial.
Zhi-Cheng Jing, Keyur Parikh, Tomas Pulido, Carlos Jerjes-Sanchez, R James White, Roblee Allen, Adam Torbicki, Kai-Feng Xu, David Yehle, Kevin Laliberte,[...]. Circulation 2013
223
11

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.
Olivier Sitbon, Marc Humbert, Xavier Jaïs, Vincent Ioos, Abdul M Hamid, Steeve Provencher, Gilles Garcia, Florence Parent, Philippe Hervé, Gérald Simonneau. Circulation 2005
697
11

Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial.
Victor F Tapson, Fernando Torres, Fiona Kermeen, Anne M Keogh, Roblee P Allen, Robert P Frantz, David B Badesch, Adaani E Frost, Shelley M Shapiro, Kevin Laliberte,[...]. Chest 2012
230
11

Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: the multicenter RePHerral study.
Roderick C Deaño, Cherylanne Glassner-Kolmin, Melvyn Rubenfire, Adaani Frost, Scott Visovatti, Vallerie V McLaughlin, Mardi Gomberg-Maitland. JAMA Intern Med 2013
89
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.